🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ESMO has just released recommendations for the use of next-generation sequencing (NGS) for patients with #AdvancedCancer which represent an expansion of the ones published in 2020. Read #ESMODailyReporter to learn more 📌ow.ly/XuNf50RXIKS

The four founding members of R.E.M. performed together publicly for the first time in nearly three decades at the Songwriters Hall of Fame Ceremony on Thursday night, playing an acoustic version of their breakthrough song, 1991’s “Losing My Religion." variety.com/2024/music/new…

Gustav Klimt, On Lake Attersee

ESMO announces the publication of the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S), a new framework to assess the tumour-agnostic potential of #CancerTherapies with the aim to optimise the drug development process Annals of Oncology. 🔗ow.ly/rqmR50T6gHt

Tre studi presentati ad #ESMO24 hanno riguardato l'impiego di un vaccino terapeutico a vantaggio della risposta immunitaria con IO o CAR-T nella gestione dei #gliomi aggressivi di alto grado, generalmente a prognosi infausta. tinyurl.com/2hxwkd8r ESMO - Eur. Oncology

#ESMO2024 does not forget the challenges in #meningioma management. We need clinical trials that address specific molecular features [from gelareh-zadeh 's insightful presentation]

🔵 #SammyBasso La scomparsa a 28 anni di Sammy Basso, biologo vicentino, scrittore, affetto da progeria, malattia che causa l'invecchiamento accelerato. "L'importanza di andare avanti anche quando sembra impossibile", diceva ieri a Venezia, dove aveva ricevuto il Premio Rizzo

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 #Oligodendroglioma: brnw.ch/21wNISX #btsm

It's the International Brain Tumour Awareness Week! IBTA EURACAN is dedicated to improving care for those affected by brain tumours.🧠 📅This week, take a moment to learn about brain tumour symptoms, share information, and support research efforts.

The immune response

Stanchi e malpagati, la metà dei medici e degli infermieri è in burnout - la Repubblica repubblica.it/cronaca/2024/1…

New year, new people, new hopes #2025

Bar, ore 10:21. A: "A vago stare in America, desso che ghe xe trump che sistema tutto. " B: "A'l voe mandarte su marte." A: "I clandestini, no mi."

Ti ho visto "pellegrino penitente" nell'#Iraq a cui nessuno prima di te, incolpevole, aveva chiesto scusa. E tra i profughi di #Lesbo. Te ne vai nel momento in cui abbiamo più bisogno. Chi chiamerà tutte le sere #Gaza? Senza meritarlo, seguiremo il tuo esempio #PapaFrancesco

Final Update CATNON ASCO 2025 · Median F/U 11 yrs · NO sig benefit concurrent TMZ · Sig benefit (HR 0.54) Adjuvant TMZ in IDHm (median OS 12.5 years) · NO benefit w/TMZ for IDHwt

Heading to Chicago - truly honoured to see the REGOMA-2 study recognized at #ASCO25 Lombardi Giuseppe Thanks Conquer Cancer, the ASCO Foundation

These posters represent just some of the #cancerresearch conducted worldwide. #impressive #unitedbycancerresearch #ASCO25

Bispecific antibodies, which can target 2 antigens or pathways at once, are being used more frequently in cancer care. An Ed Session later this morning at #ASCO25 (11:30AM, Rm S406) will discuss their role in treatment + potential adverse events: brnw.ch/21wT5I9 G Curigliano MD PhD

We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗

3 inspiring lectures at the Masterclass in #Neuroncology @ Padova 📍 Longitudinal sampling: a new frontier in GBM treatment – E. Antonio Chiocca, MD, PhD, FAANS 📍 Overcoming, bypassing & disrupting the BBB – Ahmed Idbahi 📍 A bridge over troubled waters: making vaccines work in GBM – David Reardon